Stromedix's Series B Round

Stromedix raised a round of funding on April 22, 2008.

Stromedix is a development stage biotechnology company focused on therapies for fibrosis. In February 2012, Stromedix was acquired by Biogen Idec. The valuation of Stromedix was $562.5 million.…

Articles about Stromedix's Series B Round: